Company Profile

Advanced Biodevices LLC
Profile last edited on: 9/7/23      CAGE: 54TP6      UEI: N465MQLKMR93

Business Identifier: Innovative R&D medical devices.
Year Founded
2006
First Award
2017
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1 Wall Street
Princeton, NJ 08540
   (609) 683-0215
   N/A
   novaflux.com
Location: Single
Congr. District: 12
County: Mercer

Public Profile

Endoscope?caused infections are a serious public health hazard. They are inderstood to occur primarily because the internal channels of an endoscope are long and narrow making it difficult to remove contaminants (eg biofilm) because these harbor and protect bacteria .. actually helping bacteria survive traditional high?level disinfection, Advanced Biofilm's SBIR project demonstrated that flow of a safe nanofiber?based material in an aqueous composition through an endoscope channel can scrub biofilm and other contaminants to such an extent that the channel is indistinguishable from a channel that has never been exposed to bacteria or biofilm. An unprecedented accomplishment in the endoscope reprocessing industry. Phase II was structured such as to move this technology toward commercialization with he firm developing and validating a delivery pump system. The effort was also to scalie-up the nanofiber?based cleaning composition and manufacturing processes, The firm has proceeded to testing the new technology in repeated simulated?use cycles with the most challenging three types of actual endoscopes while also testing patient?used endoscopes through multiple consecutive uses in a healthcar

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 2 NIH $3,278,572
Project Title: Improved Cleaning Technology for Reducing Risk of Transmitting Infection in Endoscopy

Key People / Management

  David A Amrhein -- President & Chief Operating Officer

  Mohamed E Labib -- President

  Stanislav S Dukhin -- Senior Scientists

  Seo Yean Sohn -- Microbiologist

  Yacoob Tabani -- Program Director

Company News

There are no news available.